Companies: 10,795·Total market cap: $144.5T
GSK plc

GSK plc

GSKNYSEHealthcare● Active
$51.52
+$0.25(+0.49%)
Market Cap$103.6B
P/E Ratio
52W High$61.7
52W Low$35.45
Overview

GSK plc (GSK) · Cash Flow

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · GSK · as of 2026-06-08

Financial statements

Operating CF · CapEx · Free Cash Flow
Breakdown2025-122024-122023-122022-122021-12
Operating Activities
Net Income$5.59B$2.95B$6.13B$5.49B$3.52B
Depreciation & Amort.$3.70B$2.55B$2.85B$2.64B$2.12B
Stock-Based Comp.$0.00B$0.34B$0.00B$0.00B$0.34B
Change in Working Capital($0.61B)$2.09B($1.06B)($1.67B)$1.39B
Net Cash from Operations$7.14B$6.55B$7.89B$8.16B$7.95B
Investing Activities
Capital Expenditure($1.32B)($2.98B)($1.63B)($1.41B)($2.65B)
Purchases of Investments($0.09B)$0.00B($0.15B)($0.18B)$0.00B
Sales of Investments$0.20B$0.02B$2.37B$0.29B$0.02B
Net Cash from Investing($5.72B)($1.23B)($2.40B)($10.88B)($1.78B)
Financing Activities
Common Stock Repurchased$0.00B$0.00B$0.00B$0.00B$0.00B
Dividends Paid($2.51B)($2.44B)($2.79B)($4.27B)($4.00B)
Debt Issued / Repaid$1.47B($1.17B)($2.95B)($5.69B)($2.00B)
Net Cash from Financing($1.59B)($4.73B)($6.07B)$2.05B($7.59B)
Free Cash Flow
Free Cash Flow$5.82B$3.57B$6.26B$6.75B$5.30B
FCF Margin %(computed)17.83%11.38%20.63%23.03%21.45%

Data source: Financial Modeling Prep · Last updated: 2026-06-08 · GBP · B

Explore more GSK plc data

About GSK plc (GSK) Cash Flow Statement

GSK plc generated operating cash flow of $7.14B and free cash flow of $5.82B for 2025 — a FCF margin of 17.83%. Capital expenditure was ($1.32B).

Frequently asked questions

GSK · 4 questions

GSK plc generated free cash flow of $5.82B for 2025, up 63.1% year-over-year.

GSK free cash flowFCF margincash flow yield

· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08